MaxCyte, Inc. (MXCT) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 4 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for MXCT is $6.00, representing a +609.9% upside from the current price of $0.8452. Price targets range from a low of $6.00 to a high of $6.00.
